Amundi Alvotech Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Alvotech stock. As of the latest transaction made, Amundi holds 11,357 shares of ALVO stock, worth $142,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,357

Previous 6,700 69.51%

Holding current value

$142,643

Previous $81,000 66.67%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$10.76 - $12.99 $50,109 - $60,494	4,657 Added 69.51%	11,357 $135,000
Q1 2024 May 15, 2024	BUY	$11.36 - $17.27 $76,112 - $115,709	6,700 New	6,700 $81,000

Others Institutions Holding ALVO

# of Institutions

Shares Held

15.5M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

3.17M
Shares

$39.9 Million
0.0% of portfolio
Bracebridge Capital, LLC

2.71M
Shares

$34 Million
28.94% of portfolio
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca

2.53M
Shares

$31.8 Million
0.64% of portfolio
Morgan Stanley New York, NY

1.74M
Shares

$21.8 Million
0.0% of portfolio
Littlejohn & CO LLC

1.32M
Shares

$16.6 Million
6.38% of portfolio

View Full List

About Alvotech

Ticker ALVO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 248,650,000
Market Cap $3.12B
Description
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...

More about ALVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account